These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10193931)

  • 1. High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin.
    Lin JC; Jan JS; Hsu CY; Wong DY
    Cancer; 1999 Apr; 85(7):1430-8. PubMed ID: 10193931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
    Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial plus i.v. chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa.
    Wang HM; Ng SH; Wang CH; Liaw CT; Chen JS; Yang TS; Chen IH
    Anticancer Drugs; 2001 Apr; 12(4):331-7. PubMed ID: 11335789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
    Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Hsu CY
    Am J Clin Oncol; 1996 Dec; 19(6):624-7. PubMed ID: 8931685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
    Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
    Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease.
    Recondo G; Cvitkovic E; Azli N; Tellez Bernal E; de Vathaire F; Wibault P; Richard JM; Marandas P; Benahmed M; Domenge C
    Cancer; 1991 Nov; 68(10):2109-19. PubMed ID: 1717121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with continuous infusion of cisplatin and fluorouracil in stage II-IV, M0 squamous cell carcinoma of the head and neck.
    Boni C; Moretti G; Savoldi L; Armaroli L; Barbieri W; Bisagni G; Caroggio A; Iotti C; Pedroni C; Manenti AL; Rondini E; Sassi M; Zadro A
    Tumori; 1996; 82(6):567-72. PubMed ID: 9061065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis.
    Lin JC; Jan JS; Hsu CY
    Cancer; 1998 Aug; 83(4):635-40. PubMed ID: 9708925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
    Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity].
    Poruban D; Koza I; Mracna J; Nagy V; Vasko J
    Bratisl Lek Listy; 1992 Aug; 93(8):395-400. PubMed ID: 1464019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
    McCaffrey R; Bahtiyar M; Kohorn EI; Chambers JT; Schwartz PE; Chambers SK
    Int J Gynecol Cancer; 2011 Apr; 21(3):535-44. PubMed ID: 21436702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma.
    Chi KH; Chan WK; Cooper DL; Yen SH; Lin CZ; Chen KY
    Cancer; 1994 Jan; 73(2):247-52. PubMed ID: 8293384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
    Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
    J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.